| Literature DB >> 1407412 |
T Yoshizawa1, H Iwamoto, H Mizusawa, N Suzuki, H Matsumoto, I Kanazawa.
Abstract
We have measured the endothelin-1 concentrations in the cerebrospinal fluid samples from 5 patients with Alzheimer's disease (AD), 6 patients with senile dementia of Alzheimer type (SDAT) and 7 patients with other diseases without dementia (disease control: DC). The cerebrospinal fluid endothelin-1 level was significantly lower in AD than in DC. No correlation was observed between cerebrospinal fluid endothelin-1 concentration and any other factors such as age, duration from onset, systolic blood pressure, cerebrospinal fluid protein level or plasma endothelin-1 concentration in AD or SDAT. These results suggest a possible alteration of the endothelin-1 system in the central nervous system in Alzheimer's disease.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1407412 DOI: 10.1016/0143-4179(92)90059-6
Source DB: PubMed Journal: Neuropeptides ISSN: 0143-4179 Impact factor: 3.286